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Abstract Clonal variation, wherein a range of specific pro-
ductivities of secreted proteins are observed from supposedly
identical transformants, is an accepted aspect of working with
Pichia pastoris. It means that a significant number of
transformants need to be tested to obtain a representative sam-
ple, and in commercial protein production, companies regu-
larly screen thousands of transformants to select for the
highest secretor. Here, we have undertaken a detailed investi-
gation of this phenomenon by characterising clones trans-
formed with the human serum albumin gene. The titers of nine
clones, each containing a single copy of the human serum
albumin gene (identified by qPCR), were measured and the
clones grouped into three categories, namely, high-, mid- and
low-level secretors. Transcriptomic analysis, using microar-
rays, showed that no regulatory patterns consistently correlat-
ed with titer, suggesting that the causes of clonal variation are
varied. However, a number of physiological changes appeared
to underlie the differences in titer, suggesting there is more
than one biochemical signature for a high-secreting strain. An
anomalous low-secreting strain displaying high transcript
levels that appeared to be nutritionally starved further empha-
sises the complicated nature of clonal variation.
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Introduction
The phenomenon of clonal variation has been noted in a va-
riety of organisms, most noticeably Chinese hamster ovary
(CHO) cells where it was first described in 1977 (Konrad
et al. 1977). Supposedly genetically identical clones plated
on agar plates showed variation in colonymorphology, as well
as variation when used for the production of recombinant
proteins. Differences were most noticeable in secreted protein
titer and highlighted an underlining heterogeneity in CHO
cells that had not previous been identified (Dahodwala et al.
2012; O’Callaghan and James 2008; Pilbrough et al. 2009).
Variation has often been attributed to differences in gene inte-
gration sites, the use of antibiotics for selection or gene copy
number (Kim et al. 2001; Zdzienicka et al. 1985). Variation in
plant cells, known as somaclonal variation, is predominantly
attributed to stress factors, although epigenetic factors such as
copy number variation, gene silencing and gene activation
have been noted (Bardini et al. 2003; Kaeppler et al. 2000;
Kidwell and Osborn 1993).
The methylotrophic yeast Pichia pastoris, reclassified
as Komagataella phaffii/pastoris, was described as show-
ing clonal variation in the mid-1980s (Cregg et al. 1989).
Indeed, clonal variation is such an integral feature that for
commercial production using P. pastoris as an expression
host, screening hundreds of clones per phenotype is
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recommended in order to identify the highest secretor
(Zheng et al . 2013). This is an extremely time-
consuming aspect of using P. pastoris, which otherwise
has the potential to be a favourable recombinant expres-
sion host, particularly after the creation of a strain with a
humanized glycosylation pattern (Hamilton and Gerngross
2007). Similarly to mammalian cells, much of the clonal
variation has been attributed to the presence of multiple
gene copies or varying integration sites (Aw and Polizzi
2013; Clare et al. 1998; Schwarzhans et al. 2016).
However, it is clear that other host-related determinants
are also operational. To date, two papers have carried out
the most comprehensive investigations into clonal varia-
tion, the first by Viader-Salvadό et al. (2006) used ampli-
fied fragment length polymorphism (ALFP). By analysing
14 transformants and three control strains, they
determined that variation predominantly arose from the
transformation process, and that the clones that most
closely resembled the host strains gave higher yields.
Schwarzhans et al. (2016) also used genomic analysis to
investigate clonal variation, yet differences in copy num-
ber and integration sites meant that their definition of
clonal variation differs from what we have outlined as
being genetically identical clones. Their findings indicat-
ed that integration loci, copy number and vector orienta-
tion were the most fundamental causes of differences to
yields.
A greater understanding of clonal variation could simplify
the process of selecting clones with a high level of secretion of
recombinant proteins. If specific markers or attributes can
identify high-copy clones, then it will be possible to use these
to look for high-secreting clones, through the use of RT-
qPCR. Alternatively, if a particular attribute is found to con-
tribute to higher secretors, then genetic engineering strains to
alter these may improve overall productivity. Selecting the
correct strain is fundamental for production and manufactur-
ing strategies, as a good secretor can reduce the need for op-
timisation of media and growth conditions (Hemmerich et al.
2014; Sreekrishna et al. 1997). In order to evaluate the prev-
alence and underlying causes of clonal variation, nine strains
were selected, each transformed with a single copy of the
human serum albumin (HSA) gene. All strains were subjected
to a wide-ranging evaluation to understand the implications of
this phenomenon.
Materials and methods
Strains and vectors
Escherichia coli DH5α (New England Bioline, London, UK)
was used for subcloning. K. phaffii, more commonly known
as P. pastoris, GS115 (HIS4-), X33 and the pPICZα and
pPICZα + HSA control strain were obtained from
Invitrogen, Carlsbad, CA. The HSA gene was amplified using
primers CCC GAA TTC ATG AAG TGG GTA ACC TTT
ATT TCC C and CCC GAA TTC AAAA ATG AAG TGG
GTA ACC TTT ATT TCC C to remove the native signal
peptide and add the restriction sites for EcoRI and NotI, re-
spectively (Fermentas, York, UK). The amplified HSA gene
was transformed into the vector pPICZα A to generate the
pPICZα-HSA strains.
Media
Buffered glycerol-complex medium (BMGY) and buffered
methanol-complex medium (BMMY) medium contained 1%
(w/v) yeast extract (Merck, Nottingham, UK), 2% (w/v) casein
peptone (Merck, Nottingham, UK), 100 mM potassium phos-
phate, pH 6.0, 1.34% (w/v) yeast nitrogen base (YNB),
4 × 10−5% (w/v) D-biotin, 1% (v/v) glycerol or 0.5% (v/v)
methanol, respectively. Yeast extract peptone medium
(YPD) contained 1% (w /v) yeast extract (Merck,
Nottingham, UK), 2% (w/v) casein peptone (Merck,
Nottingham, UK), 2% (w/v) dextrose (glucose). For agar
plates, 2% (w/v) agar was included. For selection on Zeocin,
all media were supplemented with 100 μg mL−1 Zeocin.
Transformation
Chemically competent DH5α cells were transformed accord-
ing to the manufacturer’s protocol. P. pastoris strains were
transformed as suggested by Invitrogen, Carlsbad, CA.
Briefly, 100 mL of YPD was inoculated from an overnight
culture and left to grow until OD600 1.3–1.5 cells were washed
with water and sorbitol prior to resuspension in 1 M ice-cold
sorbitol. A 5–10 μg of pPICZα-HSA digested with PmeI for
linearization was inoculated with 80 μL of the ice-cold cells.
Cells were pulsed at 2000 V, 25 μF and 200 Ω, for approxi-
mately 5 ms, using the GenePulser electroporator in 2-mm
cuvettes (Bio-Rad, Hemel Hempstead, UK). Immediately,
1 mL of ice-cold 1 M sorbitol was added to the cuvette and
the contents transferred to a sterile Eppendorf tube. The trans-
formation was incubated at 30 °C without shaking for 1–2 h,
after which the transformation was plated onto YPD plates
containing Zeocin. The plates were incubated for 3–5 days
at 30 °C. When selecting clones for analysis, single copies
were first streaked onto non-selection YPD plates, left to grow
for 3–5 days prior to being restreaked onto YPD Zeocin
plates.
Sequencing
All sequencing reactions were carried out by Eurofins MWG
Operon (Ebersberg, Germany).
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Growth conditions
Cultures were grown in 250-mL shake flasks or 24-well mi-
crotiter plates for 24 h, at 250 rpm, in the glycerol-containing
medium, BMGY. OD600 was measured and cultures normal-
ised to OD600 10. The entire culture was centrifuged for 5 min
at 4000 rpm at room temperature, the supernatant discarded
and the cells resuspended in methanol-containing BMMYand
left to grow for a further 24 h.Measurements of HSA secretion
were the mean of three biological replicates. The final OD600
for each culture was around 20 suggesting that they had all
grown at similar rates.
Titer analysis
HSA titer was determined using the albumin blue fluores-
cence assay according to the manufacturer’s instructions
(Active Motif, La Hulpe, Belgium). Fluoresence was mea-
sured at 560 nm, emission 620 nm using Synergy HT multi-
detection microplate reader (Bio-Tek, Potton, UK). All sam-
ples were measured in triplicate.
Quantitative PCR (qPCR)
For reverse transcription (RT)-qPCR, RNAwas isolated using
RiboPure—Yeast Kit according tomanufacturer’s instructions
(Applied Biosystems, Warrington, UK). Typically, 3 × 108
cells were collected, equivalent to 1 mL culture of OD600
10. Complementary DNA (cDNA) was prepared using the
High-Capacity cDNA Archive Kit (Applied Biosystems,
Warrington, UK). 1 μg RNA was used in a total reaction
volume of 20 μL. RT-qPCR reactions were set up using the
2X SYBR® Green JumpStart Taq Ready Mix (Sigma-
Aldrich, Dorset, UK). A Chromo4™ Real-Time Detector
using the thermal cycler software Opticon 3 (Bio-Rad,
Hemel Hempstead, UK) was used. Data was analysed using
the Pfaffl method, based on ΔΔCt (Livak and Schmittgen
2001; Pfaffl 2001) and normalised to ACT1 as the housekeep-
ing gene. Primers for ACT1 were GCT TTG TTC CAC CCA
TCT GT and TGC ATA CGC TCA GCA ATA CC. Primers
for HSA were GGT GTT GAT TGC CTT TGC TCA G and
GCA TTC ATT TCT CTC AGG TTC TTG. Primers for
HAC1 were CGA CTA CAT TAC TAC AGC TCC ATC A
and TGC TGT AAT GTG TAA AGATGA ATC C, for PDI
GCC GTT AAA TTC GGT AAG CA and TCA GCT CGG
TCA CAT CTT TG and for KAR2 TCA AAG ACG CTG
GTG TCA AG and TAT GCG ACA GCT TCA TCT GG.
For gene copy number determination, genomic DNAwas ex-
tracted using the DNeasy Plant Mini Kit according to the
manufacturer’s protocol (Qiagen, Crawley, UK). All other re-
action conditions were the same as with RT-qPCR.
Flow cytometry analysis
After 24 h expression in BMMY, 1 mL of culture was
collected through centrifugation and washed in 1x TBS
(0.605% Tris, 0.876% NaCl, pH adjusted with 1 M
HCl). Samples were washed for a second time before be-
ing resuspended in a final volume of 10 mL of buffer to
create a 1 in 10 dilution. Samples were stained according
to the LIVE/DEAD® FungalLight™ yeast viability kit
protocol (Invitrogen Corporation, Paisley, UK). Cells
were measured using a FACscan flow cytometer (Becton
Dickinson, Oxford, UK). Data was acquired using
CellQuest software (Becton Dickinson, Oxford, UK) with
samples measured on a high flow rate for 30 s. Data was
analysed using Cylogic software (CyFlo Ltd., Turku,
Finland).
Transcriptomic analysis
An Agilent (Agilent Technologies UK Ltd., Wokingham,
UK) 8 × 60,000 probe custom microarray was designed
by Oxford Genome Technologies (OGT, Oxford, UK)
based on the Integrated Genomics P. pastoris GS115 ge-
nome which contained 5195 open reading frames (ORFs).
Analysis was carried out at the Bacterial Microarray
Group at St George’s Hospital, London, UK. Cy3-
labelled complementary RNA (cRNA) was prepared from
1 μg total RNA using the Agilent One-Colour Quick Amp
Labelling Kit according to the manufacturer’s instructions
(Agilent Technologies UK Ltd., Wokingham, UK). One-
Colour Spike-In controls were labelled together with the
RNA samples. Purified samples were hybridised to an
Agilent 8 × 60,000 format Sureprint G3 gene expression
custom array and incubated overnight in a rotating oven
(Agilent Technologies UK Ltd., Wokingham, UK) at
65 °C, 20 rpm. After hybridization, slides were washed
for 1 min at room temperature in GE wash buffer 1 and
1 min at 37 °C in GE wash buffer 2 (Agilent Technologies
UK Ltd., Wokingham, UK), placed beneath an Ozone
Barrier Slide cover (Agilent Technologies UK Ltd.,
Wokingham, UK) and scanned immediately, using an
Agilent High-Resolution Microarray Scanner, at 2 μm
resolution. Scanned images were quantified using
Feature Extract ion software v 10.7.3.1 (Agilent
Technologies UK Ltd., Wokingham, UK). Unlike some
studies, we did not apply an artificial Bfold increase^ cut-
off at this stage on the grounds that even relatively small
changes in regulation of expression of genes such as tran-
scription factors can result in significant global responses
(Tarca et al. 2006). Furthermore, the linking of regulation
patterns through pathway analysis provides greater robust-
ness than when looking at single genes in isolation.
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Gene expression analysis
Analysis was carried out by Bioinformatics Support Service,
Imperial College London, using the Bioconductor package in
the R programming language to identify differentially
expressed genes (Gentleman et al. 2005). Each of the clonal
variation (CV) strains was contrasted to wild-type X33 in
order to determine statistically significant differences. The
empirical Bayes method was applied to identify statistical sig-
nificance in contrast between gene expression profiles (Smyth
2004). The false discovery rate (fdr) based on Benjamini and
Hochberg’s method, which assumes that all genes are statisti-
cally different from one another, was set to be less than 5%
(Smyth 2005). Gene functionality was assignedwith reference
to a created P. pastoris genome (www.blugen.org/gbrowse-
bin/gbrowse/Pichia/). All microarray data files have been
deposited into ArrayExpress (accession code A-MTAB-602).
Pathway analysis
Pathway analysis was used to identify pathways which were
significantly upregulated or downregulated in accordance
with the gene expression data. Initially, significantly upregu-
lated or downregulated genes were run through KOBAS
(KEGG Orthology Based Annotation System), which assigns
genes to pathways based on the KEGG maps specifically for
P. pastoris (Mao et al. 2005; Wu et al. 2006; Xie et al. 2011).
Once pathways were identified the KEGG Search & Colour
pathway was used to visually map the differentially expressed
genes (Kanehisa and Goto 2000; Kanehisa et al. 2012).
Results
Differences in messenger RNA (mRNA) transcript levels
variation andUPR upregulation are insufficient to explain
clonal variation
To determine the prevalence of clonal variation, 24
transformants were selected from a single transformation of
pPICzα-HSA into P. pastoris GS115 and selected on YPD
plates containing 100 μg mL−1 Zeocin. HSA titer was calcu-
lated after 24 h growth in microtiter plates in methanol-
containing medium using the albumin blue fluorescence assay
and ranged from 5 to 22.5 mg L−1 (data not shown) with a
high degree of reproducibility in biological replicates
(Fig. 1a). Each clone was then analysed by qPCR and shown
to contain a single copy of the HSA gene, and the integration
site was sequenced and found to be identical, with consistent
and faithful recombination into the AOX1 site in all cases
(Supplementary Fig. S1). Although the secretion level of the
24 transformants did not show any discrete grouping, to limit
the number of analyses three high secretors, three mid
secretors and three low secretors were selected and each
grown in a 250-mL baffled flask for 24 h in methanol-
containing medium. Whilst the inoculum was standardised,
no consideration was given to differences in growth rate or
any other contributing factor that may have impacted the titer.
The three groups were determined to be statistically indepen-
dent sets based on HSA titer (Fig. 1a). In the following anal-
ysis, high-secreting strains are identified by (H), mid-secreting
strains by (M) and low-secreting strains by (L) for ease and
convenience.
In order to explore the underlying factors determining the
variation in titer, likely indicators, including HSA transcript
levels, upregulation of components of the unfolded protein
response (UPR) and variation in growth rates/cell viability
were investigated to determine whether these might have an
effect.HSA transcript levels were determined by RT-qPCR for
each of the nine strains. Despite being statistically distinct
groups based on titer (Fig. 1a), transcript levels did not corre-
late strongly to titer levels (Fig. 1c), except with the removal
of CV7(L) as an outlier. Once this had been done, there was a
broad correlation between secreted protein titer and transcript
level, but transcript levels varied widely within each group.
CV7(L), a low secretor, showed transcript levels higher than
two of the high-secreting strains and higher than all of the mid
secretors (Fig. 1c).
The disconnection between transcript levels and secreted
protein titers in this strain points to either a reduced level of
translation or a blockage in the secretion pathway. However
HAC1, KAR2 and PDI1 expression levels (Fig. 1d) were not
significantly higher than in wild-type (indeedHAC1 and PDI1
were lower), so low protein expression cannot be explained by
protein degradation via the ER-associated degradation
(ERAD) pathway, which suggests that the low titers in this
strain potentially result from translational problems. This is
analysed inmore detail below, providing justification for treat-
ment as a special case. The variation in mid secretors also
implies that the problem of clonal variation cannot be ex-
plained solely by transcript levels, as CV8(M) shows tran-
script levels equivalent to the two low secretors, CV5(L) and
CV14(L), but secreted HSA titer was significantly higher
(Fig. 1c). However, there is a less compelling case for treating
this as an outlier. Comparison of the levels of secretion stress,
indicated by upregulation of HAC1, KAR2 and PDI between
the H, M and L groups, did not show any systematic variation
which may have explained the different titers observed
(Fig. 1d), although HAC1 expression was higher in all clones
except CV7(L). However, unless a variant had arisen with an
exceptionally sensitive UPR response, the lack of involve-
ment of UPR in clonal variation of titers derived from a single
copy of HSA is not surprising; in other studies, we and others
(Marx et al. 2009) have observed that it typically takes expres-
sion of at least five copies of the HSA gene to induce UPR
(data not shown).
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Increased cell death is evident in high secretors
Growth rates, as determined by the rate of increase in cell
density (OD600), were compared between high, mid and
low secretors, but no significant variation was observed in
either a glycerol-based or in the initial adaptation to a
methanol-based medium over 8 h (Supplementary
Fig. S2). However, as OD600 measurements do not differ-
entiate between increased cell size and increased cell
numbers nor the proportion of live cells, a live/dead cell
flow cytometric assay was performed, analysing the via-
bility of cells after growth in a glycerol-based medium
(Supplementary Fig. S3) and a methanol-based medium
(Fig. 2). Based on staining with both SYTO9® and PI,
there was no correlation between HSA titer and the pro-
portion of live/dead cells with cells grown on glycerol
medium, with both the low and high secretors showing a
similar proportion of dead cells (Supplementary Fig. S3).
However, CV2(H) was anomalous in this regard, showing
a higher proportion of dead cells than any of the other
strains, including wild-type.
When grown with methanol as the sole carbon source,
the high secretors showed an increased proportion of dead
cells compared to the other strains, with the exception of
CV7(L), which as discussed above, may be under some
form of translational stress. CV23(H) exhibited a near 1:1
ratio of live/dead cells. When grown on methanol the
proportion of dead cells in the wild-type was lower than
any of the other strains, similar to levels initially seen
when grown on glycerol, highlighting the effects of the
additional burden that protein secretion has on the cells.
The absence of any major UPR upregulation suggests that
the greater proportion of cell death in the high secretors
resulted from a different stress, possibly reflecting the
biosynthetic demand of higher levels of protein produc-
tion. Interestingly, in a cell size comparison by flow cy-
tometry, CV5(L), CV7(L) and CV14(L) were shown to
have the largest cells (data not shown).
Fig. 1 Correlation of secreted HSA titer with HSA and UPR-related
transcript levels. Clones were expressed in triplicate for 24 h in
methanol-containing medium in 250-mL baffled flasks. Green—high
secretors, yellow—mid secretors and red—low secretors. a Secreted
HSA titer levels of single copy HSA clones; error bars displayed
indicate 95% confidence interval. b HSA transcript levels of single-copy
HSA clones calculated by the ΔΔCt method in comparison to ACT1 as
the housekeeping gene. c Correlation of HSA transcript level (fold
change) with HSA titer (mg L−1). d Transcript levels of HAC1, KAR2
and PDI for each of the single-copy HSA clones calculated from
transcriptomic analysis
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Transcriptomic analysis reveals limited correlation
between titer and gene expression
In order to further understand the nature of the variation
between the strains, transcriptomic analysis was carried
out on the nine strains. Strains were grown, in triplicate,
for 24 h in glycerol medium, before being induced in
methanol medium for 24 h to allow for significant protein
production. Variations in expression compared to wild-
type with a false discovery rate (fdr) ≤ 0.05 were used
to identify differentially expressed genes (Supplementary
Fig. S4).
To gain an overview of how each of the strains had changed
after 24 h of protein expression, significantly upregulated and
downregulated genes were analysed using the programme
KOBAS to assign differentially expressed genes to KEGG
pathways (Wu et al. 2006; Xie et al. 2011). The programme
quantitatively determines the significant patterns of whole
pathway upregulation or downregulation based on the propor-
tion of genes within that pathway which are upregulated or
downregulated, with a threshold of p ≤ 0.1 (Fig. 3 and
Supplementary Tables S1 and S2).
As expected CV7(L), the strain which has already been
highlighted as suffering some sort of translational stress had
CV2(H) CV18(H) CV23(H)
CV8(M) CV15(M) CV16(M)
CV5(L) CV7(L) CV14(L)
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Fig. 2 FACS analysis of clonal
variants grown for 24 h in
methanol-containing medium.
FL1-H: SYTO9® a green
fluorescent nucleic acid stain
indicating live cells, FL2-A:
propidium iodide a red
fluorescent stain indicating dead
cells with a damaged membrane.
BG background noise. Quadrant
displays proportion of live/dead
cells and background noise
5050 Appl Microbiol Biotechnol (2017) 101:5045–5058
the highest number of KEGG-classified pathways (17) signif-
icantly upregulated and (21) downregulated compared to the
wild-type, and this strain is dealt with separately. However,
analysis of groups of commonly regulated pathways (Fig. 3)
showed that there were very few that were similarly upregu-
lated or downregulated within all members of the titer groups.
High secretors only showed two pathways which were signif-
icantly upregulated and none that were downregulated in all
clones. One of the commonly upregulated pathways was ox-
idative phosphorylation, and it is clear from the heat maps
(Supplementary Fig. S5) that a similar pattern was present in
CV16(M) and to a lesser extent CV15(M), but CV8(M),
which has already been highlighted as having a low transcript
level, was virtually identical to wild-type. Increased oxidative
phosphorylation activity is likely to be a consequence of the
increased metabolic demand for recombinant protein biosyn-
thesis, rather than an underlying cause. Interestingly, ribosome
biogenesis, which typically correlates with growth rate and
heterologous protein production, was the other commonly up-
regulated pathway. However, this was also observed in the
medium and low titer groups with the exception of CV7(L),
suggesting that heterologous protein expression is able to
increase ribosomal biogenesis in a Bdemand-led^ manner.
Increased ribosome biogenesis activity requires increased ri-
bosomal protein production to increase ribosome numbers. Of
all of the differences in expression between the selected
clones, the difference in ribosomal protein expression was
the most dramatic, although the extent of these differences
did not correlate well with HSA titer (Fig. 4). CV7(L), already
highlighted as a special case, CV14(L) and CV 16(M) all
showed particularly strong upregulation of expression of a
number of genes, many of which were common between all
three strains. Therefore, where dramatic changes in ribosomal
protein gene expression are observed, these do not correlate
directly with high HSA titer, even with the exclusion of
CV7(L) from consideration. However, all of the recombinant
strains showed some increased expression of ribosomal pro-
tein genes, matching the increase in ribosomal biogenesis and
consistent with a demand-led increase in protein synthesis in
strains expressing heterologous proteins.
In the medium titer group, the only other commonly upreg-
ulated pathway was heme biosynthesis; as with oxidative
phosphorylation, this would be a consistent response to cells
having a higher energy demand for increased protein
Fig. 3 Venn diagrams of upregulated or downregulated pathways in the
H, M and L clones. The Venn diagrams indicate the number of KEGG-
classified pathways that were significantly upregulated or downregulated
in the H, M and L clones, determined by KOBAS pathway analysis. a
Upregulated in high secretors. b Upregulated in mid secretors. c
Upregulated in low secretors. d Downregulated in high secretors. e
Downregulated in mid secretors. f Downregulated in low secretors
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synthesis. In the low titer group, the commonly upregulated
pathway was peroxisome biogenesis, which is surprising as
this is a fundamental requirement for methanol oxidation.
Whilst a correlation between increased methanol oxidation
capacity and increased protein production might have been
expected, due to the evident higher energy demand, intuitively
we would expect the low titer group to be most similar to the
wild-type. However, it is possible that a higher energy demand
for other purposes (e.g. general maintenance/repair) in these
strains could explain the lower heterologous protein produc-
tivity. Removing CV7(L) from the analysis, there were three
additional commonly upregulated KEGG groups, namely, ri-
bosome biogenesis (as discussed), purine metabolism and
RNA polymerase.
In both CV2(H) and CV18(H), the pathway Bprotein pro-
cessing in the ER^ was downregulated compared to the wild-
type strain. Whilst seemingly counter-intuitive given the
higher levels of protein secretion in these strains, this pattern
was also observed by Edwards-Jones et al. (2015).
Interestingly, a transcriptomic analysis of production of HSA
at varying μ showed that higher growth rate correlated to
upregulated genes of the secretory pathway, including UPR-
related genes (Rebnegger et al. 2014). We saw no differences
when monitoring OD600 of cells grown in BMGYand for the
first 8 h of methanol adaptation (BMMY) between the high,
mid and low secretors (Supplementary Fig. S2). The protein
processing in ER pathway is also downregulated in the low
secretors CV5(L) and CV14(L), so the effect may simply be a
response to heterologous protein expression. Given that there
is no evidence for significant ER stress in these clones, lower
protein processing in the ER probably reflects the greater en-
ergy demand in cells producing heterologous proteins
resulting in increased peroxisome and lower ER production.
Increased cell lysis can be a consequence of increased
ROS, as a consequence of increased hydrogen peroxide for-
mulation either through aerobic metabolism from mitochon-
dria or generated during the metabolism of methanol (Bener
Aksam et al. 2008; Zepeda et al. 2014). Upon investigation of
transcripts related to ROS, we found no clear trend between
the different expressing groups. For instance, YAP1
(PAS_chr4_0601), which is responsible for the deoxificiation
of ROS caused by increased protein folding (Yano et al.
2009), was significantly downregulated in CV7(L),
CV14(L), CV15(M), CV16(L) and CV18(H) compared to
wild-type, with all other strains showing no significant differ-
ence. TRX1 (PAS_chr4_0284), on the other hand, showed
upregulation in the three high-secreting strains and
CV16(M), but no significant difference in the other strains
compared to wild-type. NCE103 (PAS_chr4_0578) was up-
regulated in all of the strains compared to wild-type, whereas
for SOD2 (PAS_chr1-4_0071), only CV18(H) showed signif-
icant upregulation to wild-type, with all other strains showing
no significant differences. TSA1 (PAS_chr2-2_0220), which
has previously been reported to show strong upregulation under
hypoxia conditions (Baumann et al. 2010), showed upregula-
tion in all strains except for CV5(L), CV18(H) and CV23(H).
Therefore, from our mixed results, there is no clear consensus
regarding the upregulation of genes resulting to ROS; thus, it
is impossible to confirm that the increased cell death observed
was as a result of an increase in ROS.
The schematic representation (Fig. 5) shows that whilst no
pathways are significantly upregulated or downregulated as a
whole according to KOBAS, there are variations that indicate
differences between the strains. We have outlined key path-
ways that are involved in protein production to show how
patterns emerge within the pathways that should be taken into
consideration. Specifically, there are some individual genes
which showed consistent differentiated patterns of expression.
For instance SKP1, associated with the ERAD pathway, was
upregulated in only the high-secreting strains.
On the basis that over 5000 genes have been analysed, it is
surprising that so few genes were consistently significantly
upregulated or downregulated solely in the high secretors.
However, as the boundaries between high, mid and low secre-
tors were set arbitrarily, there may be a continuum of effects.
Certainly, there seem to be a number of genes whose expres-
sion is upregulated or downregulated solely as a result of
heterologous protein expression (particularly when CV7(L)
is excluded), and with a well-secreted protein, such as HSA,
the metabolic burden associated with the low-high range may
not be sufficient to induce dramatic stress responses. It should
be noted that, despite the small number of differences evident
in the high secretors, there were no genes that are commonly
upregulated or downregulated exclusively in the low-
secreting strains that were not similarly upregulated or down-
regulated in either the mid- or high-secreting strains. This
implies that there is no specific defect that characterises low
secretors.
CV7(L) is an anomalous strain that shows evidence
of nutrient starvation
CV7(L) showed different attributes from the other low-
secreting strains suggesting that low secretion in this strain
was due to a specific defect. Despite the low titer (Fig. 1a),
transcript levels of HSAwere equivalent to the high-secreting
strains (Fig. 1b). Furthermore, this strain showed downregu-
lation of expression of almost all of the autophagy pathway
Fig. 4 Expression levels of genes-encoding proteins involved in
ribosomal proteins. Heat maps of log 2 normalised expression levels of
genes-encoding ribosomal proteins, as defined by KEGG families,
compared to those of wild-type after 24 h induction with methanol. The
associated trees cluster genes with similar expression profiles across all
conditions
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genes, with no genes upregulated, which was a unique char-
acteristic of this particular strain (Fig. 6).
All other strains showed consistent upregulation of ATG7
(data not shown), involved in cytoplasm to vacuole transport
and is predicted to be an E1-like activating enzyme essential
for the upregulation of autophagy (Meijer et al. 2007; Yuan
et al. 1999). Furthermore, the majority of the ubiquitin-
mediated proteolysis pathway was downregulated in CV7(L)
(Supplementary Fig. S6). Autophagy is required to recycle
amino acids for either the production of proteins or for the
cellular reorganisation such as production of peroxisomes,
which are required during methanol metabolism (Dunn et al.
2005; Nazarko et al. 2011; Vanz et al. 2012). Perhaps the fact
that CV7(L) does not upregulate autophagy (more than wild-
type) indicates that this basal ability to recycle amino acids is
missing. Thus, the cell may be experiencing partial starvation,
consistent with the live/dead assay which indicates that after
24 h on methanol 32.9% of the cells were nonviable (Fig. 2).
This strain showed the highest number of genes upregulat-
ed or downregulated compared to the other strains with 3394
genes differentially expressed. As a consequence, the number
of pathways upregulated and downregulated in CV7(L) was
greater than any other strain as determined using KOBAS
pathway analysis (Table 1).
The majority of the pathways upregulated are involved in
de novo amino acid biosynthesis, metabolism and bioenerget-
ics, which supports the theory that this strain is unable to recy-
cle amino acids and is reliant on de novo biogenesis. This
clearly affects HSA translation, leading to low titers, despite
the relative abundance of cognate mRNA.
Discussion
Clonal variation is such a fundamental aspect of working with
P. pastoris that it is surprising that, to date, only a few groups
have investigated the underlying causes of this phenomenon
in detail. Viader-Salvadό et al. (2006) determined that much of
the variation arose from the process of transformation; how-
ever, they claim that when testing 17 strains (14 transformants
and 3 wild-type strains) that 16 different patterns were ob-
served. This implies that there must be some inherent variation
Fig. 5 Schematic representation of transcriptomic analysis of steps in the
pathways involved in protein production and degradation. Significantly
upregulated or downregulated genes (compared to wild-type) are
depicted with an up or down arrow, respectively. A dash indicates no
significant change compared to wild-type. Red indicates low secretors,
consistently represented in the order of CV5, CV7 and CV14, yellow
indicates mid secretors in the order of CV8, CV15 and CV16 and green
indicates high secretors in the order of CV2, CV18 and CV23
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in P. pastoris as all three control strains resulted in different
amplified fragment length polymorphism (AFLP) patterns.
Furthermore, the investigation by Schwarzhans et al. (2016)
using genome sequencing sets different standards for the iden-
tification of clonal variation. As has previously been predict-
ed, much of the variation was as a result of multi-copy clones,
Fig. 6 Downregulation of expression of genes in the autophagy pathway
of CV7(L) compared to wild-type. Microarray data was mapped using
KEGG Mapper Search & Colour pathway. Green boxes indicate
organism-specific pathways. Blue boxes show genes that are
significantly downregulated. The figure was generated using the KEGG
Mapper Search &Colour pathway programme (Kanehisa andGoto 2000;
Kanehisa et al. 2012)
Table 1 Pathways significantly
(p < 0.1) upregulated and
downregulated in CV7(L) as
determined by KOBAS pathway
analysis
Pathways upregulated in CV7(L) Pathways downregulated in CV7(L)
Ribosome Ubiquitin-mediated proteolysis
Biosynthesis of secondary metabolites Cell cycle—yeast
Oxidative phosphorylation MAPK signalling pathway—yeast
Metabolic pathways Regulation of autophagy
Cysteine and methionine metabolism Nucleotide excision repair
Lysine biosynthesis Mismatch repair
Valine, leucine and isoleucine biosynthesis Meiosis—yeast
Phenylalanine, tyrosine and tryptophan biosynthesis Proteasome
Alanine, aspartate and glutamate metabolism DNA replication
Ubiquinone and other terpenoid-quinone biosynthesis Endocytosis
Terpenoid backbone biosynthesis Natural killer cell-mediated cytotoxicity
Peroxisome SNARE interactions in vesicular transport
Sulphur metabolism Folate biosynthesis
Aminoacyl-tRNA biosynthesis
mRNA surveillance pathway
Tyrosine metabolism
Phenylalanine metabolism
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vector orientation and loci integration (Aw and Polizzi 2013;
Clare et al. 1998; Schwarzhans et al. 2016).
Our in-depth assessment into clonal variation, first and
foremost, identifies that differences in titer cannot be solely
attributed to integration site or copy number unlike those ob-
served by Schwarzhans et al. (2016). Whilst we did not check
whether the method of transformation has an effect on the
strains, unlike Viader-Salvadό et al. (2006), electroporation
was used rather than spheroplasting, which is deemed more
stable (Cregg 2007). Looking at titer and transcript of the
heterologous protein alone shows variation occurring that
could be attributed to transcriptional blockages (CV8(M)),
as well as translational blockages (CV7(L)). This initial inves-
tigation highlights that strains differ in secreted protein titer for
multiple reasons.
The transcriptomic analysis further highlights the fact that
no single attribute is clearly responsible for the presence of
high or low secretors. No pathways were either consistently
upregulated or downregulated that could be solely attributed
to the production of a higher titer of HSA. Additionally, the
same can be said for the low secretors, where no pathways
were statistically different from the mid and high secretors.
However, some individual genes, such as SKP1, showed up-
regulated or downregulated expression in all the high secre-
tors. Future work could utilise these target genes to determine
whether these genes are consistently upregulated when other
proteins are secreted.
The increase in ribosomes in a demand-led manner con-
trasts with the current picture of tight control of ribosomal
biogenesis based on nutritional status and growth rate,
although Santoro et al. (2009) have shown that it is possible
to artificially switch on silent ribosomal RNA (rRNA) gene
expression in some mammalian cell lines, which increased
growth rate and heterologous protein production
independently of nutritional status. Lin et al. (2013) saw that
in a low-expressing strain, five ribosome biogenesis genes
were downregulated compared to nine that were upregulated
in a high-expressing strain. They determined that higher ex-
pression required higher translation rates for protein synthesis.
Furthermore, our finding correlates with research by Graf
et al. (2008) who determined that a large number of ribosome
biogenesis-related genes were upregulated upon the induction
of UPR either through HAC1 overexpression or when chem-
ically inducing UPR with DTT. The authors noted that this
trend was different to what had been previously noted with
Saccharomyces cerevisiae where upregulation of the UPR
through DTT resulted in downregulation of ribosome biogen-
esis genes (Payne et al. 2008).
As the protein secretion pathway did not show significant
upregulation or variation between strains, it was unlikely that
specific proteolytic activity association with ER stress
(ERAD) would be increased in high secretors. However, gen-
eral proteolysis associated with proteasomal activity does
appear to be activated in the high secretors (Fig. 5), which is
significant given the evidence for increased cell lysis of these
strains. Whilst both of these effects are likely to be conse-
quences rather than causes of high secretion, increased
proteasomal activity in the absence of ER stress could poten-
tially be investigated further to determine its feasibility to be
used as a biomarker of high productivity. If key targets regu-
larly show upregulation, irrespective of the protein being pro-
duced, then this could be used with RT-qPCR to determine
whether this strain will be a high secretor. This will become
evenmore important if experiments into bioreactors determine
that similar trends are detectable at both large and small scale,
allowing for a more robust analysis of high secretors.
Furthermore, identifying potential biomarkers could result in
identifying targets for metabolic engineering, which has been
the case for YAP1 overexpression. YAP1was initially found to
be involved in controlling reactive oxygen species (ROS)
(Yano et al. 2009). Delic et al. (2012) determined that in-
creased oxidative protein folding led to changes in the redox
state of the cytosol and this had an impact on protein expres-
sion. Future work then determined that overexpression of
YAP1 led to a rebalancing of the redox conditions and in-
creased protein yield (Delic et al. 2014).
Fundamentally, the microarray analysis raises the question
as to whether clonal variation reflects degrees of impairment
of secretion or enhancement. Based on indications from
Viader-Salvadό et al. (2006), it would be the former with
strains that maintain similarities to the wild-type strain show-
ing the highest titers. This could certainly be argued for
CV7(L), which showed the highest variation compared to
wild-type. Interestingly, the mid secretors showed the least
variation from wild-type, with an average of 2513 genes sta-
tistically variable from wild-type compared to 3197 in low
secretors and 2944 in high secretors. As observed by Viader-
Salvadό et al. (2006), there is clearly some inherent variation
within the wild-type strain, which may account for a lot of the
clonal variation observed in the transformants. Characterising
this will be essential for future studies.
The increased cell death in the high-secreting strains could
lend itself to the development of even higher-secreting strains,
if cell death could be reduced. This has been investigated by
Weis et al. (2004) who limited cell death through a strict feed-
ing strategy. It was ascertained that cell death increased with
starvation, which is evident in CV7(L) (Fig. 2) and is known
to occur in both shake flasks as well as microtiter plates.
Therefore, repeating these experiments in a controlled-feed
environment may further differentiate the strains and shed
more light on the underlying causes of clonal variation. Our
experimental procedure using shake flasks did not allow us to
tightly control growth parameters, as would be the case with
bioreactors. However, it is important to note that during initial
strain selection, most screening is performed on small scale,
either using microtiter plates or shake flasks. It would be of
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fundamental value to investigate whether similar trends are
observable using strict feeding regimes using bioreactors.
Furthermore, Rebnegger et al. (2014) showed with
transcriptomic analysis that a higherμ resulted in upregulation
of protein secretion-related proteins, including UPR genes.
Therefore, attempts to characterise a feeding programme with
the high secretors with an increased μ and an decreased cell
death may result in a more pronounced transcriptomic profile
showing differences between the high, mid and low secretors
(Rebnegger et al. 2014).
Clonal variation in P. pastoris is often attributed to differ-
ences in copy number and the integration site of the vector.
However, our in-depth experiments show that significant var-
iation occurs due to factors other than vector integration.
Whilst we were unable to pinpoint precise underlying causes
of clonal variation, we have highlighted the prevalence and
begun to investigate identifiers that could be utilised in future
experiments. This raises the question as to where the major
variation arises, whether from intrinsic differences within the
host strain population or whether the transformation or selec-
tion method can give rise to the variation seen. A study of
variation within the host strain could provide a mechanism
for preselection of potentially good secretors for transforma-
tion, thus minimising the subsequent screening exercise.
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